ArticleAdvances in radiation oncology

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer.

Melissa A L Vyfhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.